Reelin deficiency or dysfunction and methods related thereto

Details for Australian Patent Application No. 2005208832 (hide)

Owner Martek Biosciences Corporation

Inventors Ellis, Lorie A.; Morseman, John P.; Moss, Mark W.

Agent Allens Arthur Robinson

Pub. Number AU-A-2005208832

PCT Pub. Number WO2005/072306

Priority 60/537,600 19.01.04 US; 60/605,219 27.08.04 US

Filing date 19 January 2005

Wipo publication date 11 August 2005

International Classifications

A61K 31/20 (2006.01)

Event Publications

13 July 2006 PCT application entered the National Phase

  PCT publication WO2005/072306 Priority application(s): WO2005/072306

11 August 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005208834-CGRP receptor antagonists

2005208821-Methods for reducing oxidative damage